Location History:
- South San Francisco, CA (US) (2006)
- Brentwood, TN (US) (2003 - 2014)
Company Filing History:
6 out of 3,222 
3 out of 114 
1 out of 4 Years Active: 2003-2014
Title: Innovations and Contributions of Gregory T. Stelzer
Introduction
Gregory T. Stelzer is a notable inventor based in Brentwood, TN (US), recognized for his significant contributions to the field of drug-target binding assays. With a total of 10 patents to his name, Stelzer has made remarkable advancements in the analysis of drug interactions at the cellular level.
Latest Patents
Stelzer's latest patents include innovative methods for simultaneous assays of target and target-drug binding. One of his notable inventions involves a whole cell assay that utilizes differentially labeled antibodies and flow cytometry. In this method, the first antibody binds to the total target, while the second antibody targets the drug binding site. This competitive inhibition assay allows for detailed kinetic assessments of drug activity, even in mixed populations of cells. Another patent focuses on the analysis of free drug in samples, employing a similar approach to provide comprehensive insights into drug-target interactions.
Career Highlights
Throughout his career, Gregory T. Stelzer has worked with prominent companies such as Genentech, Inc. and Laboratory Corporation of America Holdings. His experience in these organizations has contributed to his expertise in the development of innovative assays and drug analysis techniques.
Collaborations
Stelzer has collaborated with esteemed colleagues, including Mary Beth Gardiner and Mark X. Sliwkowski, further enhancing the impact of his work in the field of drug research and development.
Conclusion
Gregory T. Stelzer's contributions to the field of drug-target binding assays exemplify his innovative spirit and dedication to advancing scientific research. His patents and collaborations reflect a commitment to improving drug analysis methodologies, making a significant impact in the industry.